Evaluation of Mast Cell Activation Syndromes: Impact of Pathology and Immunohistology
International Archives of Allergy and Immunology, 05/17/2012
Horny HP et al. – When the activating point mutant KIT D816V is detectable but criteria for diagnosis of mastocytosis are not completely met, a so–called (mono)clonal Mast cell activation syndromes (MCAS) as a subvariant of primary MCAS should be diagnosed.



